Pancreatic Cancer Research

ResearcherCapital Medical UniversityNo recent work listed

Kun Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7608-1335; OpenAlex author ID A5100683519. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 3

  1. CHST12: a potential prognostic biomarker related to the immunotherapy response in pancreatic adenocarcinoma. Co-author DOI 10.3389/fendo.2023.1226547↗
  2. A nomogram predicting overall survival for metastatic pancreatic cancer: SEER database analysis Co-author DOI 10.21203/rs.3.rs-1410601/v1↗
  3. Prognostic value of leukemia inhibitory factor and its receptor in pancreatic adenocarcinoma. First author DOI 10.2217/fon-2019-0684↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guang Han · 1 shared paper, 2023 · strength 0.31
  2. Lu Li · 1 shared paper, 2023 · strength 0.31
  3. Jiaoshun Chen · 1 shared paper, 2022 · strength 0.16
  4. Tao Yin · 1 shared paper, 2022 · strength 0.16
  5. Haoxiang Zhang · 1 shared paper, 2022 · strength 0.16
  6. Taoyu Chen · 1 shared paper, 2022 · strength 0.16
  7. Heshui Wu · 1 shared paper, 2022 · strength 0.16
  8. Wei Guo · 1 shared paper, 2020 · strength 0.13
  9. Dong Wang · 1 shared paper, 2020 · strength 0.13
  10. Zhongtao Zhang · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.